Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorGulley, James L.
dc.contributor.authorBorre, Michael
dc.contributor.authorVogelzang, Nicholas J.
dc.contributor.authorNg, Siobhan
dc.contributor.authorAgarwal, Neeraj
dc.contributor.authorParker, Chris C.
dc.contributor.authorCarles Galceran, Joan
dc.date.accessioned2021-03-11T14:25:03Z
dc.date.available2021-03-11T14:25:03Z
dc.date.issued2019-05-01
dc.identifier.citationGulley JL, Borre M, Vogelzang NJ, Ng S, Agarwal N, Parker CC, et al. Phase III Trial of PROSTVAC in asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer. J Clin Oncol. 2019;37(13):1051–61.
dc.identifier.issn1527-7755
dc.identifier.urihttp://hdl.handle.net/11351/5751
dc.descriptionProstate cancer; Metastatic neoplasm; Immunotherapy
dc.language.isoeng
dc.publisherAmerican Society of Clinical Oncology
dc.relation.ispartofseriesJournal of Clinical Oncology;37(13)
dc.rightsAttribution 4.0 International
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectPròstata - Càncer - Tractament
dc.subjectVacunes contra el càncer
dc.subjectMetàstasi
dc.subject.meshProstatic Neoplasms, Castration-Resistant
dc.subject.meshNeoplasm Metastasis
dc.subject.meshCancer Vaccines
dc.titlePhase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1200/JCO.18.02031
dc.subject.decsneoplasias prostáticas resistentes a la castración
dc.subject.decsmetástasis neoplásica
dc.subject.decsvacunas del cáncer
dc.relation.publishversionhttps://ascopubs.org/doi/10.1200/JCO.18.02031
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Gulley JL] National Institutes of Health, Bethesda, MD. [Borre M] Aarhus Universitetshospital, Åarhus, Denmark. [Vogelzang NJ] Comprehensive Cancer Centers of Nevada, Las Vegas, NV. [Ng S] St John of God Subiaco Hospital, Subiaco, Western Australia, Australia. [Agarwal N] University of Utah Huntsman Cancer Institute, Salt Lake City, UT. [Carles J] Genitourinary, CNS and Sarcoma Tumors Program, Vall d’Hebron Institute of Oncology, Barcelona, Spain. Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid30817251
dc.identifier.wos000468265100005
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record